This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lilly Diabetes And Disney Publishing Worldwide Expand Collaboration

INDIANAPOLIS, April 30, 2013 /PRNewswire/ --

News Highlights:
  • Lilly Diabetes expands collaboration with Disney Publishing Worldwide globally.
  • New educational resources will be available soon for families of children with type 1 diabetes.

Lilly Diabetes today announced the global expansion of its innovative collaboration with Disney Publishing Worldwide (DPW), which expands the program internationally based on the success of the initiative in the U.S., which began in 2011. The goal of the program is to bring thoughtful educational resources to families of children with diabetes, including a series of custom books co-created by Lilly Diabetes and DPW for children of various ages and stages of life who are living with type 1 diabetes. The books, available through diabetes healthcare professionals, will initially be translated and available in 18 countries.

"Lilly Diabetes' objective is to bring safety, health, comfort and a bit of magic to children worldwide," said Andrew Hodge, vice president, International, Lilly Diabetes. "We saw the positive impact our collaboration with Disney Publishing Worldwide had on families living with type 1 diabetes in the U.S. over the last two years, and we are excited to expand our reach globally."

Nearly 500,000 young people worldwide are living with type 1 diabetes, and an estimated 78,000 are diagnosed each year.[1] From the moment of diagnosis to the day-in, day-out management of the disease, the challenges of living with the disease can be overwhelming for children and their families. People with type 1 diabetes must follow a structured self-management regimen that includes a balance of medication, physical activity and a healthy diet.[1]

By expanding this collaboration, Lilly Diabetes and DPW hope to reach even more families who have been impacted by type 1 diabetes – emphasizing what they can do instead of what they can't do, and offering stories of familiar characters, such as Mickey Mouse and his friend Coco, the fun-loving monkey who has type 1 diabetes.

"We are excited to be part of this effort to bring informational material about type 1 diabetes to kids around the world who are living with the disease," said Andrew Sugerman, executive vice president, DPW. "Lilly Diabetes' expertise with the disease, combined with Disney's tradition of great storytelling, gives us an opportunity to inspire and motivate children and families with type 1 diabetes."

About Disney Publishing WorldwideDisney Publishing Worldwide (DPW) is the world's largest publisher of children's books and magazines with over 700 million products sold each year. Disney Publishing Worldwide consists of an extensive worldwide licensing structure as well as vertically integrated publishing imprints, including Disney Book Group in the U.S., Disney Libri in Italy, and Disney Libros in Spain. DPW publishes a range of children's magazines globally, including Topolino, Le Journal de Mickey, and Donald Duck , as well as Disney kids magazines in the U.S., which include Disney Princess and Phineas and Ferb. Disney English is DPW's English language learning business, which includes Disney English learning centers in China and a worldwide retail licensing program. DPW's digital products include bestselling eBook titles as well as original apps. Headquartered in Glendale, California, Disney Publishing Worldwide publishes books, magazines, and digital products in 85 countries in 75 languages. For more information visit

About Lilly DiabetesLilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions—from medicines to support programs and more—to make lives better. For more information, visit

About Eli Lilly and Company (NYSE: LLY)Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers—through medicines and information—for some of the world's most urgent medical needs. Information about Lilly is available at


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs